FIA
DNA icon

FNY Investment Advisers’s Ginkgo Bioworks DNA Stock Holding History

FNY Investment Advisers’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Sell
14,966
-414
-3% -$3.46K 0.05% 277
2026
Q1 		$94K Buy
15,380
+5,080
+49% +$42.3K 0.04% 292
2025
Q4 		$85K Sell
10,300
-3,265
-24% -$35.2K 0.02% 365
2025
Q3 		$197K Sell
13,565
-136,406
-91% -$1.63M 0.06% 274
2025
Q2 		$1.69M Buy
149,971
+16,380
+12% +$127K 0.71% 33
2025
Q1 		$761K Buy
133,591
+57,625
+76% +$587K 0.46% 57
2024
Q4 		$745K Buy
75,966
+42,298
+126% +$363K 0.39% 60
2024
Q3 		$274K Buy
33,668
+29,249
+662% +$293K 0.13% 145
2024
Q2 		$59K Buy
4,419
+1,619
+58% +$48.3K 0.04% 234
2024
Q1 		$129 Sell
2,800
-245
-8% -$12.7K 0.08% 163
2023
Q4 		$205K Buy
3,045
+2
+0.1% +$122 0.23% 87
2023
Q3 		$220K Buy
3,043
+2
+0.1% +$160 0.13% 99
2023
Q2 		$226K Buy
3,041
+625
+26% +$37K 0.29% 62
2023
Q1 		$128K Sell
2,416
-190
-7% -$12K 0.15% 115
2022
Q4 		$176K Buy
2,606
+789
+43% +$72.6K 0.25% 88
2022
Q3 		$226K Sell
1,817
-750
-29% -$89.4K 0.16% 89
2022
Q2 		$244K Buy
2,567
+384
+18% +$46.8K 0.18% 84
2022
Q1 		$351K Buy
2,183
+1,991
+1,037% +$388K 0.33% 62
2021
Q4 		$63K Sell
192
-1,053
-85% -$500K 0.03% 240
2021
Q3 		$577K Buy
+1,245
New +$606K 0.27% 80

Other funds holding DNA

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BSWM
Boston Standard Wealth Management Winchester, Massachusetts $689M AUM 16.24% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return

FNY Investment Advisers's DNA Position: Q2 2026 in Review

FNY Investment Advisers reduced its Ginkgo Bioworks (DNA) stake by 2.7% in Q2 2026, selling an estimated $3.46K and leaving 14,966 shares worth $148K. The position accounts for 0.05% of the portfolio, ranked #277.

FNY Investment Advisers first reported a position in DNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.69M in Q2 2025. 37 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • FNY Investment Advisers held 14,966 shares of Ginkgo Bioworks worth $148K as of Q2 2026.
  • FNY Investment Advisers sold 414 Ginkgo Bioworks shares in Q2 2026, an estimated $3.46K.
  • Ginkgo Bioworks made up 0.05% of FNY Investment Advisers's portfolio in Q2 2026, its #277 holding.
  • FNY Investment Advisers first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 20 quarters since.
  • FNY Investment Advisers's Ginkgo Bioworks position peaked at $1.69M in Q2 2025.
  • 37 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.